A randomised controlled trial to identify Obstructive Sleep Apnoea (OSA) in primary care

Not Applicable

• Conditions: Case finding of obstructive sleep apnoea in primary care; Respiratory

• Registration Number: ISRCTN16982033
• Lead Sponsor: niversity of Warwick

Brief Summary

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39059802/ (added 29/07/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-03
• Last Update Posted: 12 August 2024
• Study Completion: 2025-04-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 1426

Inclusion Criteria

1. Age 50 - 70 years
2. BMI>=30 kg/m² as of GP records in the last 3 years
3. Diabetes (type 1 or 2) OR hypertension (office BP > 140/90 mmHg or on treatment) OR both diabetes and hypertension

Exclusion Criteria

1. Patients with known OSA
2. Patients with known moderate-to-severe COPD
3. Those deemed unable to take part by their GP (e.g. terminally ill)
4. Patients with known allergy to acrylate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 26/06/2024: <br><br>To compare the detection rate of moderate-to-severe OSA in high-risk groups within General Practice between the intervention and usual care groups between randomisation and 6 months follow-up general practice notes review.<br><br>_____<br><br>Previous primary outcome measure:<br><br>Number of participants diagnosed with moderate-to-severe OSA, defined as an AHI reading of 15 to 30 (moderate) or >30 (severe) episodes per hour from the AcuPebble report (intervention group) or GP notes review at six months (control group).